scispace - formally typeset
Open AccessJournal ArticleDOI

Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage

TLDR
The treatment of participants with intracerebral hemorrhage to achieve a target systolic blood pressure of 110 to 139mm Hg did not result in a lower rate of death or disability than standard reduction to a target of 140 to 179 mm Hg.
Abstract
BackgroundLimited data are available to guide the choice of a target for the systolic blood-pressure level when treating acute hypertensive response in patients with intracerebral hemorrhage. MethodsWe randomly assigned eligible participants with intracerebral hemorrhage (volume, <60 cm3) and a Glasgow Coma Scale (GCS) score of 5 or more (on a scale from 3 to 15, with lower scores indicating worse condition) to a systolic blood-pressure target of 110 to 139 mm Hg (intensive treatment) or a target of 140 to 179 mm Hg (standard treatment) in order to test the superiority of intensive reduction of systolic blood pressure to standard reduction; intravenous nicardipine to lower blood pressure was administered within 4.5 hours after symptom onset. The primary outcome was death or disability (modified Rankin scale score of 4 to 6, on a scale ranging from 0 [no symptoms] to 6 [death]) at 3 months after randomization, as ascertained by an investigator who was unaware of the treatment assignments. ResultsAmong 1000...

read more

Citations
More filters
Journal ArticleDOI

The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)

TL;DR: The story of the life and times of Toshihiko Umemura and his family in the years leading up to and including his death.
References
More filters
Journal ArticleDOI

US valuation of the EQ-5D health states: development and testing of the D1 valuation model.

TL;DR: The D1 model best predicts the values for observed health states using the time trade-off method, and represents a significant enhancement of the EQ-5D's utility for health status assessment and economic analysis in the US.
Journal ArticleDOI

Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage

TL;DR: Recombinant activated factor VII was associated with a 38% relative reduction in mortality and significantly improved functional outcome among survivors, despite a 5% frequency of arterial thromboembolic events (primarily ischemic stroke and myocardial infarction).
Journal ArticleDOI

Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group.

TL;DR: Evidence-based guidelines are presented for the diagnosis of intracerebral hemorrhage, the management of increased arterial blood pressure and intracranial pressure, the treatment of medical complications of intrusion, and the prevention of recurrent intrusion.
Journal ArticleDOI

Enlargement of Spontaneous Intracerebral Hemorrhage Incidence and Time Course

TL;DR: Although expansion of intracerebral hemorrhage on CT scan was common in the hyperacute stage, 17% of hematoma expansion occurred even after 6 hours of onset, early CT scanning appears to increase the rate of detection of enlarging hematomas.
Related Papers (5)